quarta-feira, 7 de outubro de 2026
PesquisarExplore
pt.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 26, 2026

Take the Zacks Approach to Beat the Markets: Drilling Tools, Alcoa & Starbucks in Focus

View original at finance.yahoo.com
Take the Zacks Approach to Beat the Markets: Drilling Tools, Alcoa & Starbucks in Focus Major U.S. indexes like the Nasdaq Composite, the S&P 500 and the Dow Jones Industrial Average rallied 2.4%, 1.8%, and 1.3%, respectively, during holiday-shortened trading last week…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Zacks ECDP returned -0.6% in 2025 vs. +6.8% for NOBL

    80% confidence

  • Since 2012, Top 10 portfolio produced cumulative return of +2,472.7% vs. +561.6% for S&P 500 and +403.3% for equal-weight version

    80% confidence

  • Zacks ECAP portfolio returned -2.3% in Q4 2025 vs. S&P 500's +2.7% gain

    80% confidence

  • Suggested a collaborative framework for Greenland during World Economic Forum at Davos summit

    80% confidence

  • Zacks ECAP returned +16.26% in 2024 vs. +24.89% for S&P 500

    80% confidence

  • Top 10 portfolio produced average annual return of +25.8% from 2012 through 2025 vs. +13.1% for S&P 500 and +10.5% for equal-weight version

    80% confidence

  • Zacks Focus List portfolio returned +22.1% in 2025 vs. +17.9% for the S&P 500 index and +11.4% for equal-weight version

    80% confidence

  • Zacks ECAP returned -1.67% for full year 2025 vs. S&P 500's +17.9% gain

    80% confidence

  • Over 10-year period (2016-2025), equal-weight Zacks Rank #1 stocks portfolio outperformed equal-weight S&P 500 by more than 7 percentage points (+18.55% vs. +11.65%)

    80% confidence

  • Zacks Top 10 portfolio returned +62.98% in 2024 vs. +25.04% for S&P 500 and +13% for equal-weight version

    80% confidence

  • Zacks Focus List portfolio returned -15.2% in 2022 vs. S&P 500's -17.96%

    80% confidence

  • Zacks ECDP returned -2.1% in Q4 2025 vs. S&P 500's +2.7% gain and NOBL's +1.6% return

    80% confidence

  • Fresh tariff threats to countries opposing acquisition of Greenland

    80% confidence

  • Zacks Focus List portfolio returned +18.41% in 2024 vs. +25.04% for S&P 500 and +13% for equal-weight S&P 500

    80% confidence

  • Equal-weight portfolio of Zacks Rank #1 stocks outperformed the equal-weight S&P 500 index by 7 percentage points (+17.81% vs. +10.85%)

    80% confidence

  • Zacks Focus List portfolio returned +29.54% in 2023 vs. +26.28% for S&P 500 and +13.61% for equal-weight S&P 500

    80% confidence

  • Zacks Top 10 portfolio returned +22.6% in 2025 vs. +17.9% for S&P 500 and +11.4% for equal-weight version

    80% confidence

  • Hypothetical equal-weight portfolio returned +22.4% in 2024 vs. +13.7% for the equal-weight S&P 500 index

    80% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
A nossa leitura dos dados ›
Sinais que acompanhamos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,985
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,985 factos verificados com a fonte5,351 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Take the Zacks Approach to Beat the Markets: Drilling Tools, Alcoa & Starbucks in Focus — Source | Via News | pt.VIA.NEWS